Effect of Thoracic Mobilization on Lumbar Radiculopathy

December 4, 2023 updated by: aya abd elmohsen salah eldeen, Cairo University

Effect of Thoracic Spine Mobilization on Pain, Functional Disability and Proprioception in Patients With Lumbosacral Radiculopathy.

The purpose of the study will be to:

  • To investigate the effect of thoracic mobilization on back and leg pain in patients with lumbosacral radiculopathy.
  • To investigate the effect of thoracic mobilization on functional disability in patients with lumbosacral radiculopathy.
  • To investigate the effect of thoracic mobilization on proprioception in patients with lumbosacral radiculopathy.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

To investigate the effect of thoracic mobilization on back and leg pain, functional disability and proprioception in patients with lumbosacral radiculopathy.

1-Thirty four patients of both sexes with unilateral chronic lumbar radiculopathy at L4-L5 or/ and L5-S1 levels will participate in this study. The patients will be diagnosed as having lumbar radiculopathy based on careful clinical examination by neurologist . The diagnosis will be confirmed by CT scan or MRI.

Patients will be recruited from the outpatient clinic of Faculty of Physical Therapy, Cairo University and private clinics. Patients in this study will be randomly divided into two groups.

  • Group (I) which will include 17 patients who will receive manual mobilization exercises in addition to selected physical therapy .
  • Group (II) which will include 17 patients who will receive selected physical therapy.

The treatment will conducted 3 sessions per week for 6 weeks.

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Faculty of Physical Therapy Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients with unilateral chronic lumbosacral radiculopathy at L4- L5 or / and L5-S1 levels confirmed by MRI.
  2. The age of patients will be ranged from 30 to 45 years.
  3. Duration of pain will be more than 12 weeks.
  4. Patients with a positive straight leg raising (SLR) test.
  5. Patients with sufficient cognitive abilities that enables them to understand and follow instructions .
  6. Patients had to report an average pain level of more than five on the Visual Analogue Scale (VAS) and a lumbar spine range of motion (ROM) of at least 50% of the accepted normal range.
  7. Patients with body mass index< 30kg/m2

Exclusion Criteria:

  1. Cauda equina syndrome.
  2. Ankylosing spondylitis, thoracic deformities (pectus carinatum, excavatum), spina bifida, fractures, postoperative spinal conditions, diabetes, inflammatory processes.
  3. Previous inner ear infection or vestibular disorder with unresolved balance disturbance, history of head trauma with residual neurological deficits.
  4. Spinal tumor.
  5. Previous lumbar surgery.
  6. Sever musculoskeletal disease.
  7. Peripheral mononeuropathies or polyneuropathy.
  8. Obesity .
  9. Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: thoracic mobilization group
which will include 17 patients who will receive thoracic manual mobilization exercises in addition to selected physical therapy .The treatment will conducted for 45 minutes, 3 sessions per week for 6 weeks.
Thoracic mobilization will be performed for the thoracic spine mobilization group, thoracic mobilization therapy will be performed for five minutes.
No Intervention: control group
which will include 17 patients who will receive selected physical therapy.The treatment will conducted for 45 minutes, 3 sessions per week for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional disability
Time Frame: baseline
we will use Oswestry Disability Index (ODI)
baseline
pain level
Time Frame: baseline
we will use Visual analogue scale (VAS)
baseline
lumbar proprioception
Time Frame: baseline
we will use The Biodex System 3 pro isokinetic dynamometer
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Nagwa Ibrahim Rehab, Assistant Professor, physical therapy for neuromuscular disorder and its surgery
  • Study Chair: Ebtesam Mohamed Fahmy, Professor, Faculty of Medicine
  • Study Chair: HOSSAM MOHAMMED MOHAMMED, Lecturer, physical therapy for neuromuscular disorder and its surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 19, 2023

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

February 1, 2024

Study Registration Dates

First Submitted

December 4, 2023

First Submitted That Met QC Criteria

December 4, 2023

First Posted (Actual)

December 12, 2023

Study Record Updates

Last Update Posted (Actual)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 4, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • thoracic mobilization in LR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbosacral Radiculopathy

Clinical Trials on thoracic mobilization

3
Subscribe